Evaluating new and existing drug-eluting stents in everyday clinical practice
Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
CardioVascular Research Foundation, Korea · NCT01186133
This study tests how well a new type of heart stent works compared to older ones for patients with coronary artery disease who need a procedure to open blocked arteries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | CardioVascular Research Foundation, Korea (other) |
| Locations | 1 site (Multiple Locations) |
| Trial ID | NCT01186133 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness and safety of a new drug-eluting stent (DES) compared to earlier generations of DES in real-world clinical settings. It involves consecutive patients who receive the new DES without the use of other types of stents. The study focuses on patients with coronary artery disease who are eligible for percutaneous coronary intervention (PCI). By analyzing outcomes in a routine clinical practice environment, the study seeks to provide insights into the performance of these stents.
Who should consider this trial
Good fit: Ideal candidates are patients with coronary disease that can be treated with percutaneous coronary intervention and who meet the study's inclusion criteria.
Not a fit: Patients with terminal illnesses or those experiencing cardiogenic shock may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with coronary artery disease.
How similar studies have performed: Other studies have shown success in evaluating drug-eluting stents, but this specific comparison in routine practice may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several DES * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock
Where this trial is running
Multiple Locations
- Korean centres — Multiple Locations, South Korea (RECRUITING)
Study contacts
- Study coordinator: Seung-Jung Park, MD
- Email: sjpark@amc.seoul.kr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty, coronary disease, drug eluting stent